Toxicity of the antimalarial artemisinin and its dervatives

References

• Adjuik M, Babiker A, Garner P, Olliaro P, Taylor W, White N. (2004). International Artemisinin Study Group. Artesunate combinations for treatment of malaria: Meta-analysis. Lancet 363:9–17.
   PubMed Web of Science ®Google Scholar
• Afonso A, Hunt P, Cheesman S, Alves AC, Cunha C.V, do Rosario V, Cravo P. (2006). Malaria parasites can develop stable resistance to artemisinin but lack mutations in candidate genes atp6 (encoding the sarcoplasmic and endoplasmic reticulum Ca2+ ATPase), tctp, mdr1, and cg10. Antimicrob Agents Chemother 50: 480–489.
   PubMed Web of Science ®Google Scholar
• Ai J, Gao HH, He SZ, Wang L, Luo DL, Yang B.F. (2001). Effects of matrine artemisinin tetrandrine on cytosolic [Ca2+]i in guinea pig ventricular myocytes. Acta Pharmacol Sin 22: 512–515.
   PubMed Web of Science ®Google Scholar
• Akinlolu AA, Shokunbi MT. (2008). Neurotoxic effects of 25mg/kg/bodyweight of artemether on the histology of the trapezoid nuclei and behavioural functions in adult male Wistar rats. Acta Histochem. Epub ahead of print.
   Google Scholar
• Bardelmeijer H.A, van Tellingen O, Schellens JH, Beijnen JH. (2000). The oral route for the administration of cytotoxic drugs: Strategies to increase the efficiency and consistency of drug delivery. Invest New Drugs 18: 231–241.
   PubMed Web of Science ®Google Scholar
• Barradell LB, Fitton A. (1995). Artesunate: A review of its pharmacology and therapeutic efficacy in the treatment of malaria. Drugs 50: 714–741.
   PubMed Web of Science ®Google Scholar
• Beekman A.\C, Wierenga P.\K, Woerdenbag HJ, Van Uden W, Pras N, Konings AW, el-Feraly FS, Galal AM, Wikström HV. (1998). Artemisinin-derived sesquiterpene lactones as potential antitumour compounds: Cytotoxic action against bone marrow and tumour cells. Planta Med 64: 615–619.
   PubMedGoogle Scholar
• Berger TG, Dieckmann D, Efferth T, Schultz ES, Funk JO, Baur A, Schuler G. (2005). Artesunate in the treatment of metastatic uveal melanoma—First experiences. Oncol Rep 14: 1599–1603.
   PubMed Web of Science ®Google Scholar
• Bethell DB, Phuong PT, Phuong CX, Nosten F Waller D, Davis TM, Day NP, Crawley J, Brewster D, Pukrittayakamee S, White NJ. (1996). Electrocardiographic monitoring in severe falciparum malaria. Trans R Soc Trop Med Hyg 90: 266–269.
   Google Scholar
• Bindschedler M, Lefèvre G, Degen P, Sioufi A. (2002). Comparison of the cardiac effects of the antimalarials co-artemether and halofantrine in healthy participants. Am J Trop Med Hyg 66: 293–298.
   PubMed Web of Science ®Google Scholar
• Boareto AC, Muller JC, Bufalo AC, Botelho GG, de Araujo SL, Foglio MA, de Morais RN, Dalsenter PR. (2008). Toxicity of artemisinin [Artemisia annua L.] in two different periods of pregnancy in Wistar rats. Reprod Toxicol 25:239–246.
   PubMedGoogle Scholar
• Brabin BJ, Wasame M, Uddenfeldt-Wort U, Dellicour S, Hill J, Gies S. (2008). Monitoring and evaluation of malaria in pregnancy—Developing a rational basis for control. Malar J. 7(Suppl 1):S6.
   Google Scholar
• Brewer TG, Grate SJ, Peggins JO, Weina PJ, Petras JM, Levine BS, Heiffer MH, Schuster BG. (1994). Fatal neurotoxicity of arteether and artemether. Am J Trop Med Hyg 51: 251–259.
   PubMed Web of Science ®Google Scholar
• Bunnag D, Poltera AA, Viravan C, Looareesuwan S, Harinasuta KT, Schindléry C. (1992). Plasmodicidal effect of desferrioxamine B in human vivax or falciparum malaria from Thailand. Acta Trop 52: 59–67.
   PubMed Web of Science ®Google Scholar
• Chen H, Maibach HI. (1994). Topical application of artesunate on guinea pig allergic contact dermatitis. Contact Dermatitis 30: 280–282.
   Google Scholar
• Chen LJ, Wang MY, Sun WK, Liu MZ. (1984). [Embryotoxicity and teratogenicity studies on artemether in mice rats and rabbits] [Chinese]. Zhongguo Yao Li Xue Bao 5:118–122.
   PubMedGoogle Scholar
• Chen M, Kappel M, Lemnge M, Bygbjerg IC, Theander TG, Kharazmi A. (1994). In vitro effects of artesunate and other antimalarial agents on the function of human lymphocytes and neutrophils. Transplant Proc 26: 3172–3174.
   Google Scholar
• Chen M, Zhu ZJ, Wang ZL, Mo HL, Yang ZP, Zhang MA. (2002). Effect of sodium artesunate on immune function of animals. Acta Guangxi Med Coll 5:42–44.
   Google Scholar
• China Cooperative Research Group on qinghaosu and its derivatives as antimalarials. (1982). Studies on the toxicity of qinghaosu and its derivatives. J Tradit Chin Med 2:31–38.
   Google Scholar
• Clark RL. (2009). Embryotoxicity of the artemisinin antimalarials and potential consequences for use in women in the first trimester. Reprod Toxicol. 28:285–96.
   PubMed Web of Science ®Google Scholar
• Clark RL, White TE, A Clode S, Gaunt I, Winstanley P, Ward SA. (2004). Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit. Birth Defects Res B Dev Reprod Toxicol 71: 380–394.
   PubMed Web of Science ®Google Scholar
• Clark RL, Lerman SA, Cox EM, Gristwood WE, White TE. (2008a). Developmental toxicity of artesunate in the rat: Comparison to other artemisinins, comparison of embryotoxicity and kinetics by oral and intravenous routes, relationship to maternal reticulocyte count. Birth Defects Res B Dev Reprod Toxicol 83: 397–406.
   PubMed Web of Science ®Google Scholar
• Clark RL, Arima A, Makori N, Nakata Y, Bernard F, Gristwood W, Harrell A, White TE, Wier PJ. (2008b). Artesunate: Developmental toxicity and toxicokinetics in monkeys. Birth Defects Res B Dev Reprod Toxicol 83: 418–434.
   PubMed Web of Science ®Google Scholar
• Classen W, Altmann B, Gretener P, Souppart C, Skelton-Stroud P, Krinke G. (1999). Differential effects of orally versus parenterally administered qinghaosu derivative artemether in dogs. Exp Toxicol Pathol 51: 507–516.
   Google Scholar
• de Vries PJ, Dien T.K. (1996). Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria. Drugs 52: 818–836.
   PubMed Web of Science ®Google Scholar
• Dell’Eva R, Pfeffer U, Vené R, Anfosso L, Forlani A, Albini A, Efferth T. (2004). Inhibition of angiogenesis in vivo and growth of Kaposi’s sarcoma xenograft tumors by the anti-malarial artesunate. Biochem Pharmacol 68: 2359–2366.
   PubMed Web of Science ®Google Scholar
• Dellicour S, Hall S, Chandramohan D, Greenwood B. (2007). The safety of artemisinins during pregnancy: A pressing question. Malar J. 6:15.
   PubMed Web of Science ®Google Scholar
• Dokomajilar C, Nsobya SL, Greenhouse B, Rosenthal PJ, Dorsey G. (2006). Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic. Antimicrob Agents Chemother 50: 1893–1895.
   PubMed Web of Science ®Google Scholar
• Duffy PE, Mutabingwa T.K. (2006). Artemisinin combination therapies. Lancet 367: 2037–2039.
   PubMed Web of Science ®Google Scholar
• Eckstein-Ludwig U, Webb RJ, Van Goethem ID, East JM, Lee AG, Kimura M, O’Neill PM, Bray PG, Ward SA, Krishna S. (2003). Artemisinins target the SERCA of Plasmodium falciparum. Nature 424: 957–961.
   PubMed Web of Science ®Google Scholar
• Efferth T. (2005). Mechanistic perspectives for 124-trioxanes in anti-cancer therapy. Drug Resist Updat 8:85–97.
   PubMed Web of Science ®Google Scholar
• Efferth T. (2006). Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells. Curr Drug Targets 7:407–421.
   PubMed Web of Science ®Google Scholar
• Efferth T. (2007). Willmar Schwabe Award 2006: Antiplasmodial and antitumor activity of artemisinin—From bench to bedside. Planta Med 73: 299–309.
   PubMed Web of Science ®Google Scholar
• Efferth T, Oesch F. (2004). Oxidative stress response of tumor cells: Microarray-based comparison between artemisinins and anthracyclines. Biochem Pharmacol 68: 3–10.
   PubMedGoogle Scholar
• Efferth T, Rücker G, Falkenberg M, Manns D, Olbrich A, Fabry U, Osieka R. (1996). Detection of apoptosis in KG-1a leukemic cells treated with investigational drugs. Arzneimittelforschung 46: 196–200.
   PubMedGoogle Scholar
• Efferth T, Dunstan H, Sauerbrey A, Miyachi H, Chitambar CR. (2001). The anti-malarial artesunate is also active against cancer. Int J Oncol 18: 767–773.
   PubMed Web of Science ®Google Scholar
• Efferth T, Olbrich A, Bauer R. (2002a). mRNA expression profiles for the response of human tumor cell lines to the antimalarial drugs artesunate, arteether, and artemether. Biochem Pharmacol 64: 617–623.
   PubMed Web of Science ®Google Scholar
• Efferth T, Davey M, Olbrich A, Rücker G, Gebhart E, Davey R. (2002b). Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells. Blood Cells Mol Dis 28: 160–168.
   PubMed Web of Science ®Google Scholar
• Efferth T, Briehl MM, Tome ME. (2003a). Role of antioxidant genes for the activity of artesunate against tumor cells. Int J Oncol 23: 1231–1235.
   PubMedGoogle Scholar
• Efferth T, Sauerbrey A, Olbrich A, Gebhart E, Rauch P, Weber HO, Hengstler JG, Halatsch ME, Volm M, Tew KD, Ross DD, Funk JO. (2003b). Molecular modes of action of artesunate in tumor cell lines. Mol Pharmacol 64: 382–394.
   PubMed Web of Science ®Google Scholar
• Efferth T, Benakis A, Romero MR, Tomicic M, Rauh R, Steinbach D, Häfer R, Stamminger T, Oesch F, Kaina B, Marschall M. (2004a). Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron. Free Radic Biol Med 37: 998–1009.
   PubMed Web of Science ®Google Scholar
• Efferth T, Ramirez T, Gebhart E, Halatsch ME. (2004b). Combination treatment of glioblastoma multiforme cell lines with the anti-malarial artesunate and the epidermal growth factor receptor tyrosine kinase inhibitor OSI-774. Biochem Pharmacol 67: 1689–1700.
   PubMed Web of Science ®Google Scholar
• Efferth T, Giaisi M, Merling A, Krammer PH, Li-Weber M. (2007). Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells. PLoS One 2:e693.
   Google Scholar
• Ejiofor JI, Kwanashie HO, Anuka JA. (2006). Some pregnancy-related effects of artemether in laboratory animals. Pharmacology 77: 166–170.
   Google Scholar
• El-Dakdoky MH. (2009). Evaluation of the developmental toxicity of artemether during different phases of rat pregnancy. Food Chem Toxicol 47: 1437–1441.
   PubMed Web of Science ®Google Scholar
• Elias Z, Bonnet E, Marchou B, Massip P. (1999). Neurotoxicity of artemisinin: Possible counseling and treatment of side effects. Clin Infect Dis 28:1330–1331.
   PubMed Web of Science ®Google Scholar
• Ezzedine K, Pistone T, Receveur MC, Cressend T, Diéval C, Malvy D. (2007). Haemoglobinuria in a 38-year-old French expatriate man living in Cameroon following artemisinin-based antimalarial treatment. Travel Med Infect Dis 5:256–258.
   Google Scholar
• Fishwick J, McLean WG, Edwards G, Ward SA. (1995). The toxicity of artemisinin and related compounds on neuronal and glial cells in clulture. Chem Biol Interact 96: 263–271.
   PubMed Web of Science ®Google Scholar
• Fishwick J, Edwards G, Ward SA, McLean WG. (1998a). Morphological and immunocytochemical effects of dihydroartemisinin on differentiating NB2a neuroblastoma cells. Neurotoxicology 19: 393–403.
   Google Scholar
• Fishwick J, Edwards G, Ward SA, McLean WG. (1998b). Binding of dihydroartemisinin to differentiating neuroblastoma cells and rat cortical homogenate. Neurotoxicology 19: 405–412.
   Google Scholar
• Franco-Paredes C, Dismukes R, Nicolls D, Kozarsky PE. (2005). Neurotoxicity due to antimalarial therapy associated with misdiagnosis of malaria. Clin Infect Dis 40: 1710–1711.
   PubMedGoogle Scholar
• Genovese RF, Petras JM, Brewer TG. (1995). Arteether neurotoxicity in the absence of deficits in behavioural performance in rats. Ann Trop Med Parasitol 89: 447–449.
   PubMed Web of Science ®Google Scholar
• Genovese RF, Newman DB, Petras JM, Brewer TG. (1998). Behavioral and neural toxicity of arteether in rats. Pharmacol Biochem Behav 60: 449–458.
   PubMed Web of Science ®Google Scholar
• Genovese RF, Newman D.B, Gordon KA, Brewer TG. (1999). Acute high dose arteether toxicity in rats. Neurotoxicology 20:851–859.
   PubMed Web of Science ®Google Scholar
• Genovese RF, Newman DB, Brewer TG. (2000). Behavioral and neural toxicity of the artemisinin antimalarial, arteether, but not artesunate and artelinate, in rats. Pharmacol Biochem Behav 67: 37–44.
   PubMed Web of Science ®Google Scholar
• Genovese RF, Nguyen HA, Mog SR. (2001). Effects of arteether on an auditory radial-arm maze task in rats. Physiol Behav 73: 87–91.
   Google Scholar
• Gladman DD, Urowitz MB, Senecal JL, Fortin PJ, Petty RE, Esdaile JM. (1983). Aspects of use of antimalarials in systemic lupus erythematosus. J Rheumatol 25: 983–985.
   Google Scholar
• Goldring JP, Nemaorani S. (1999). Antimalarial drugs modulate the expression of monocyte receptors. Int J Immunopharmacol 21: 599–607.
   PubMedGoogle Scholar
• Gomes MF, Faiz MA, Gyapong JO, Warsame M, Agbenyega T, Babiker A, Baiden F, Yunus EB, Binka F, Clerk C, Folb P, Hassan R, Hossain MA, Kimbute O, Kitua A, Krishna S, Makasi C, Mensah N, Mrango Z, Olliaro P, Peto R, Peto TJ, Rahman MR, Ribeiro I, Samad R, White NJ, Study 13 Research Group. (2009). Pre-referral rectal artesunate to prevent death and disability in severe malaria: A placebo-controlled trial. Lancet 373: 557–566.
   PubMed Web of Science ®Google Scholar
• Gordi T, Lepist E.I. (2004). Artemisinin derivatives: Toxic for laboratory animals safe for humans? Toxicol Lett 147: 99–107.
   PubMed Web of Science ®Google Scholar
• Gu YX, Cui YF, Wu BA, Shi XC, Teng XH. (1989). Effects of artemether on peripheral T B T mu and T gamma lymphocytes in beagle dog. J Tradit Chin Med 9:215–219.
   Google Scholar
• Guo X-B, Fu L-C, Yu C-G, Jian H-X, Li G-Q. (1990). A study on tolerance and toxic side-effects of artesunate intravenous injection on healthy volunteers/clinical trials Phase I. In: Li G-Q, Guo XB, Fu XB, eds. Clinical Trials on Qinghaosu and Its Derivatives, Guangzhou College of Traditional Chinese Medicine. China: Sanya Tropical Medicine Institute Guanzhou, 39–43.
   Google Scholar
• Hien TT, White NJ. (1993). Qinghaosu. Lancet 341: 603–608.
   PubMed Web of Science ®Google Scholar
• Hien TT, Day NPJ, Phu NH, Mai NTH, Chau TTH, Loc PP, Singh DX, Chuong LV, Vinh H, Waller D, Peto TEA, White NJ. (1996). A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med 335:76–83.
   PubMed Web of Science ®Google Scholar
• Hutagalung R, Htoo H, Nwee P, Arunkamomkiri J, Zwang J, Carrara V.I, Ashley E, Singhasivanon P, White NJ, Nosten F. (2006). A case-control auditory evaluation of patients treated with artemether-lumefantrine. Am J Trop Med Hyg 74: 211–214.
   PubMed Web of Science ®Google Scholar
• Jambou R, Legrand E, Niang M, Khim N, Lim P, Volney B, Ekala M.T, Bouchier C, Esterre P, Fandeur T, Mercereau-Puijalon O. (2005). Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. Lancet 366: 1960–1963.
   PubMed Web of Science ®Google Scholar
• Kager PA, Schultz MJ, Zijlstra EE, van den Berg B, van Boxtel C. (1994). Arteether administration in humans: Preliminary studies of pharmacokinetics safety and tolerance. Trans R Soc Trop Med Hyg 88: 53–54.
   PubMed Web of Science ®Google Scholar
• Kamchonwongpaisan S, McKeever P, Hossler P, Ziffer H, Meshnick SR. (1997). Artemisinin neurotoxicity: Neuropathology in rats and mechanistic studies in vitro. Am J Trop Med Hyg 56: 7–12.
   PubMed Web of Science ®Google Scholar
• Karbwang J, Laothavorn P, Sukontason K, Thiha T, Rimchala W, Na-Bangchang K, Bunnag D. (1997). Effect of artemether on electrocardiogram in severe falciparum malaria. Southeast Asian J Trop Med Public Health 28:472–475.
   PubMedGoogle Scholar
• Kelter G, Steinbach D, Konkimalla V.B, Tahara T, Taketani S, Fiebig HH, Efferth T. (2007). Role of transferrin receptor and the ABC transporters ABCB6 and ABCB7 for resistance and differentiation of tumor cells towards artesunate. PLoS ONE 2:e798.
   Google Scholar
• Kissinger E, Hien TT, Hung NT, Nam ND, Tuyen NL, Dinh BV, Mann C, Phu NH, Loc PP, Simpson JA, White NJ, Farrar JJ. (2000). Clinical and neurophysiological study of the effects of multiple doses of artemisinin on brain-stem funtion in Vietnamese patients. Am J Trop Med Hyg 63: 48–55.
   PubMed Web of Science ®Google Scholar
• Knights P. (2002). Artesunate: 14 day preliminary oral (gavage administration) toxicity study in the rat. Covance Report Number 1552/051-D6154. GlaxosmithKline report number CD2005/00545/00.
   Google Scholar
• Konkimalla VB, Blunder M, Korn B, Soomro S.A, Jansen H, Chang W, Posner GH, Bauer R, Efferth T. (2008). Effect of artemisinins and other endoperoxides on nitric oxide-related signaling pathway in RAW 264.7 mouse macrophage cells. Nitric Oxide 19: 184–191.
   PubMed Web of Science ®Google Scholar
• Konkimalla VB, McCubrey JA, Efferth T. (2009). The role of downstream signaling pathways of the epidermal growth factor receptor for artesunate’s activity in cancer cells. Curr Cancer Drug Targets 9:72–80.
   Google Scholar
• Korenromp EL, for the RBM MERG Task Force on Malaria Morbidity. (2005). Malaria Incidence Estimates at Country Level for the Year 2004—Proposed Estimates and Draft Report. Available at:http://apps.who.int/malaria/docs/incidence_estimations2.pdf. Accessed August 13, 2009.
   Google Scholar
• Krishna S, Planche T, Agbenyega T, Woodrow C, Agranoff D, Bedu-Addo G, Owusu-Ofori AK, Appiah JA, Ramanathan S, Mansor SM, Navaratnam V. (2001). Bioavailability and preliminary clinical efficacy of intrarectal artesunate in Ghanaian children with moderate malaria. Antimicrob Agents Chemother 45: 509–516.
   PubMed Web of Science ®Google Scholar
• Krishna S, Uhlemann AC, Haynes RK. (2004). Artemisinins: Mechanisms of action and potential for resistance. Drug Resist Updat 7:233–244.
   PubMed Web of Science ®Google Scholar
• Krishna S, Woodrow CJ, Staines HM, Haynes RK, Mercereau-Puijalon O. (2006). Re-evaluation of how artemisinins work in light of emerging evidence of in vitro resistance. Trends Mol Med 12: 200–205.
   PubMed Web of Science ®Google Scholar
• Leonardi E, Gilvary G, White NJ, Nosten F. (2001). Severe allergic reactions to oral artesunate: A report of two cases. Trans R Soc Trop Med Hyg 95: 182–183.
   PubMed Web of Science ®Google Scholar
• Li GQ, Guo XB, Fu Y. (1990). Clinical Trials on Qinghaosu and Its Derivatives: Guangzhou College of Traditional Chinese Medicine. China: Sanya Tropical Medicine Institute Guanzhou.
   Google Scholar
• Li QG, Peggins JO, Fleckenstein LL, Masonic K, Heiffer MH, Brewer TG. (1998). The pharmacokinetics and bioavailability of dihydroartemisinin, arteether, artemether, artesunic acid and artelinic acid in rats. J Pharm Pharmacol 50: 173–182.
   PubMed Web of Science ®Google Scholar
• Li QG, Brueckner RP, Peggins JO, Trotman KM, Brewer TG. (1999). Arteether toxicokinetics and pharmacokinetics in rats after 25 mg/kg/day single and multiple doses. Eur J Drug Metab Pharmacokinet 24: 213–223.
   PubMedGoogle Scholar
• Li QG, Mog SR, Si YZ, Kyle DE, Gettayacamin M, Milhous WK. (2002). Neurotoxicity and efficacy of arteether related to its exposure times and exposure levels in rodents. Am J Trop Med Hyg 66: 516–525.
   PubMed Web of Science ®Google Scholar
• Li W, Mo W, Shen D, Sun L, Wang J, Lu S, Gitschier JM, Zhou B. (2005). Yeast model uncovers dual roles of mitochondria in action of artemisinin. PLoS Genet 1:e36.
   PubMed Web of Science ®Google Scholar
• Li WD, Dong YJ, Tu YY, Lin ZB. (2006). Dihydroarteanniun ameliorates lupus symptom of BXSB mice by inhibiting production of TNF-alpha and blocking the signaling pathway NF-kappa B translocation. Int Immunopharmacol 6:1243–1250.
   PubMed Web of Science ®Google Scholar
• Li LN, Zhang HD, Yuan SJ, Tian ZY, Wang L, Sun ZX. (2007a). Artesunate attenuates the growth of human colorectal carcinoma and inhibits hyperactive Wnt/beta-catenin pathway. Int J Cancer 121: 1360–1365.
   Google Scholar
• Li Q, Xie LH, Johnson TO, Si Y, Haeberle AS, Weina PJ. (2007b). Toxicity evaluation of artesunate and artelinate in Plasmodium berghei-infected and uninfected rats. Trans R Soc Trop Med Hyg 101: 104–112.
   PubMed Web of Science ®Google Scholar
• Li PC, Lam E, Roos WP, Zdzienicka MZ, Kaina B, Efferth T. (2008a). Artesunate derived from traditional Chinese medicine induces DNA damage and repair. Cancer Res 68: 4347–4351.
   PubMed Web of Science ®Google Scholar
• Li Q, Si Y, Smith KS, Zeng Q, Weina PJ. (2008b). Embryotoxicity of artesunate in animal species related to drug tissue distribution and toxicokinetic profiles. Birth Defects Res B Dev Reprod Toxicol 83:435–445.
   Google Scholar
• Lin PY, Feng ZM, Pan JQ, Zhang D, Xiao LY. (1995). Effects of artesunate on immune function in mice. Zhongguo Yao Li Xue Bao 16: 441–444.
   Google Scholar
• Longo M, Zanoncelli S, Torre P.D, Riflettuto M, Cocco F, Pesenti M, Giusti A, Colombo P, Brughera M, Mazué G, Navaratman V, Gomes M, Olliaro P. (2006). In vivo and in vitro investigations of the effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos. Reprod Toxicol 22: 797–810.
   PubMedGoogle Scholar
• Longo M, Zanoncelli S, Della Torre P, Rosa F, Giusti A, Colombo P, Brughera M, Mazué G, Olliaro P. (2008). Investigations of the effects of the antimalarial drug dihydroartemisinin (DHA) using the Frog Embryo Teratogenesis Assay-Xenopus (FETAX). Reprod Toxicol 25: 433–441.
   PubMedGoogle Scholar
• Looareesuwan S, Wilairatana P, Vannaphan S, Gordeuk VR, Taylor TE, Meshnick SR, Brittenham G.M. (1996). Co-administration of desferrioxamine B with artesunate in malaria: An assessment of safety and tolerance. Ann Trop Med Parasitol 90: 551–554.
   PubMed Web of Science ®Google Scholar
• Matuschewski K, Mueller AK. (2007). Vaccines against malaria—An update. FEBS J 274: 4680–4687.
   PubMed Web of Science ®Google Scholar
• McGready R, Cho T, Samuel Villegas L, Brockman A, van Vugt M, Looareesuwan S, White NJ, Nosten F. (2001a). Randomized comparison of quinine-clindamycin versus artesunate in the treatment of falciparum malaria in pregnancy. Trans R Soc Trop Med Hyg 95: 651–656.
   PubMed Web of Science ®Google Scholar
• McGready R, Stepniewska K, Lindegardh N, Ashley EA, La Y, Singhasivanon P, White NJ, Nosten F. (2006). The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria. Eur J Clin Pharmacol 62: 1021–1031.
   PubMed Web of Science ®Google Scholar
• McLean WG, Ward S.A. (1998). In vitro neurotoxicity of artemisinin derivatives. Med Trop (Mars). 58(3 Suppl):28–31.
   Google Scholar
• Menard D, Matsika-Claquin M.D, Djalle D, Yapou F, Manirakiza A, Dolmazon V, Sarda J, Talarmin A. (2005). Association of failures of seven-day courses of artesunate in a non-immune population in Bangui Central African Republic with decreased sensitivity of Plasmodium falciparum. Am J Trop Med Hyg 73: 616–621.
   PubMed Web of Science ®Google Scholar
• Meshnick SR, Taylor TE, Kamchonwongpaisan S. (1996). Artemisinin and the antimalarial endoperoxides: From herbal remedy to targeted chemotherapy. Microbiol Rev 60: 301–315.
   PubMedGoogle Scholar
• Miller LG, Panosian CB. (1997). Ataxia and slurred speech after artesunate treatment for falciparum malaria. N Engl J Med 336: 1328.
   PubMed Web of Science ®Google Scholar
• Moore JC, Lai H, Li JR Ren RL, McDougall JA, Singh NP, Chou CK. (1995). Oral administration of dihydroartemisinin and ferrous sulfate retarded implanted fibrosarcoma growth in the rat. Cancer Lett 98: 83–87.
   PubMed Web of Science ®Google Scholar
• Mordente A, Meucci E, Silvestrini A, Martorana GE, Giardina B. (2009). New developments in anthracycline-induced cardiotoxicity. Curr Med Chem 16: 1656–1672.
   PubMed Web of Science ®Google Scholar
• Navaratnam V, Mansor SM, Sit NW, Grace J, Li Q, Olliaro P. (2000). Pharmacokinetics of artemisinin-type compounds. Clin Pharmacokinet 39: 255–270
   PubMed Web of Science ®Google Scholar
• Nealon C, Dzeing A, Müller-Römer U, Planche T, Sinou V Kombila M, Kremsner PG, Parzy D, Krishna S. (2002). Intramuscular bioavailability and clinical efficacy of artesunate in gabonese children with severe malaria. Antimicrob Agents Chemother 46: 3933–3939.
   PubMed Web of Science ®Google Scholar
• Noker PE, Simpson-Herren L. (1998). Whole body autoradiography of 14C-artelinic acid in rats. Birmingham, AL: Southern Research Institute. (Data on file.)
   Google Scholar
• Nontprasert A, Pukrittayakamee S, Nosten-Bertrand M, Vanijanonta S, White NJ. (2000). Studies of the neurotoxicity of oral artemisinin derivatives in mice. Am J Trop Med Hyg 62: 409–412.
   PubMedGoogle Scholar
• Nontprasert A, Pukrittayakamee S, Dondorp AM, Clemens R, Looareesuwan S, White NJ. (2002a). Neuropathologic toxicity of artemisinin derivatives in a mouse model. Am J Trop Med Hyg 67: 423–429.
   PubMed Web of Science ®Google Scholar
• Nosten F, McGready R, d’Alessandro U, Bonell A, Verhoeff F, Menendez C, Mutabingwa T, Brabin B. (2006). Antimalarial drugs in pregnancy: A review. Curr Drug Saf 1:1–15.
   PubMedGoogle Scholar
• Olliaro PL, Taylor W.R. (2003). Antimalarial compounds: From bench to bedside. J Exp Biol 206: 3753–3759.
   PubMed Web of Science ®Google Scholar
• Panossian LA, Garga NI, Pelletier D. (2005). Toxic brainstem encephalopathy after artemisinin treatment for breast cancer. Ann Neurol 58: 812–813.
   PubMed Web of Science ®Google Scholar
• Park BK, O’Neill PM, Maggs L, Pirmohamed M. (1998). Safety assessment of peroxide antimalarials: Clinical and chemical perspectives. Br J Clin Pharmacol 46: 521–529.
   PubMed Web of Science ®Google Scholar
• Petras JM, Kyle DE, Gettayacamin M, Young GD, Bauman RA, Webster HK, Corcoran KD, Peggins JO, Vane MA, Brewer TG. (1997). Arteether: Risks of two-week administration in Macaca mulatta. Am J Trop Med Hyg 56: 390–396.
   Web of Science ®Google Scholar
• Petras JM, Young GD, Bauman RA, Kyle DE, Gettayacamin M, Webster HK, Corcoran KD, Peggins JO, Vane MA, Brewer TG. (2000). Arteether-induced brain injury in Macaca mulatta. I. The precerebellar nuclei: The lateral reticular nuclei paramedian reticular nuclei, and perihypoglossal nuclei. Anat Embryol (Berl) 201: 383–397.
   PubMedGoogle Scholar
• Pirmohamed M, Atuah KN, Dodoo AN, Winstanley P. (2007). Pharmacovigilance in developing countries. BMJ 335: 462.
   PubMed Web of Science ®Google Scholar
• Qian RS, Li ZL, Yu J.L, Ma DJ. (1981). Immunomodulatory action and anti virus effect of Qinghaosu. Trad Chin Med J 6:63–66.
   Google Scholar
• Qian RS, Li ZL, Xie MY, Xu L, Liang MS, Liu X. (1987). Influence of Qinghaosu on the phagocytosis function of macrophages. Chin Trad Herbal Drug 18: 14–24.
   Google Scholar
• Ramacher M, Umansky V, Efferth T. (2009). Effect of artesinate on immune cells in rat-transgenic mouse melanoma model. Anticancer Drugs 20:910–917.
   Google Scholar
• Reinhart H, Hughson C, de Palacios PI. (2005). Comment on: Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether. Trans R Soc Trop Med Hyg 99:315–316; author reply 316–317.
   Google Scholar
• Ribeiro IR, Olliaro P. (1998). Safety of artemisinin and its derivatives. A review of published and unpublished clinical trials. Med Trop (Mars). 58(3 Suppl):50–53.
   Google Scholar
• Rowland M, Tower TN. (1994). Clinical Pharmacokinetics: Concepts and Applications. 3rd ed. Media, PA: Williams and Wilkins.
   Google Scholar
• Sachs J, Malaney P. (2002). The economic and social burden of malaria. Nature 415: 680–685.
   PubMed Web of Science ®Google Scholar
• Schmuck G, Roehrdanz E, Haynes RK, Kahl R. (2002). Neurotoxic mode of action of artemisinin. Antimicrob Agents Chemother 46: 821–827.
   PubMedGoogle Scholar
• Shen M, Ge HL, He YX, Song QL, Zhang H.Z. (1984). Immunosuppressive action of Qinghaosu. Sci Sin B 27: 398–406.
   Google Scholar
• Si Y, Li Q, Xie L, Bennett K, Weina PJ, Mog S, Johnson TO. (2007). Neurotoxicity and toxicokinetics of artelinic acid following repeated oral administration in rats. Int J Toxicol 26:401–410.
   PubMed Web of Science ®Google Scholar
• Simpson JA, Agbenyega T, Barnes KI, Di Perri G, Folb P, Gomes M, Krishna S, Krudsood S, Looareesuwan S, Mansor S, McIlleron H, Miller R, Molyneux M, Mwenechanya J, Navaratnam V, Nosten F, Olliaro P, Pang L, Ribeiro I, Tembo M, van Vugt M, Ward S, Weerasuriya K, Win K, White NJ. (2006). Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients. PLoS Med 3:e444.
   PubMed Web of Science ®Google Scholar
• Sisowath C, Strömberg J, Martensson A, Msellem M, Obondo C, Björkman A, Gil JP. (2005). In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether lumefantrine (Coartem). J Infect Dis 191: 1014–1017.
   PubMed Web of Science ®Google Scholar
• Smith SL, Fishwick J, McLean WG, Edwards G, Ward SA. (1997). Enhanced in vitro neurotoxicity of artemisinin derivatives in the presence of haemin. Biochem Pharmacol 53: 5–10.
   PubMed Web of Science ®Google Scholar
• Smith SL, Maggs JL, Edwards G, Ward SA, Park BK, McLean WG. (1998). The role of iron in neurotoxicity: A study of novel antimalarial drugs. Neurotoxicology 19:557–559.
   Google Scholar
• Smith SL, Sadler CJ, Dodd CC, Edwards G, Ward SA, Park BK, McLean WG. (2001). The role of glutathione in the neurotoxicity of artemisinin derivatives in vitro. Biochem Pharmacol 61: 409–416.
   PubMed Web of Science ®Google Scholar
• Staedke SG, Jagannathan P, Yeka A, Bukirwa H, Banek K, Maiteki-Sebuguzi C, Clark TD, Nzarubara B, Njama-Meya D, Mpimbaza A, Rosenthal PJ, Kamya MR, Wabwire-Mangen F, Dorsey G, Talisuna AO. (2008). Monitoring antimalarial safety and tolerability in clinical trials: A case study from Uganda. Malar J 7:107.
   PubMedGoogle Scholar
• Stepniewska K, Day N, Babiker A, Lalloo D, Warrell D, Olliaro P, White NJ. (2001). A meta-analysis using individual patient data of trials comparing artemether with quinine in the treatment of severe falciparum malaria. Trans R Soc Trop Med Hyg 95: 637–650.
   Google Scholar
• Svensson US, Ashton M. (1999). Identification of the human cytochrome P450 enzymes involved in the in vitro metabolism of artemisinin. Br J Clin Pharmacol 48: 528–535.
   PubMed Web of Science ®Google Scholar
• Talisuna AO, Staedke SG, D’Alessandro U. (2006). Pharmacovigilance of antimalarial treatment in Africa: Is it possible? Malar J 5:50.
   PubMedGoogle Scholar
• Tam LS, Gladman DD, Hallett DC, Rahman P, Urowitz M.B. (2000). Effect of antimalarial agents on the fasting lipid profile in systemic lupus erythematosus. J Rheumatol 27: 2142–2145.
   PubMed Web of Science ®Google Scholar
• Taylor WR, White NJ. (2004). Antimalarial drug toxicity: A review. Drug Saf 27: 25–61.
   PubMed Web of Science ®Google Scholar
• Teja-Isavadharm P, Nosten F, Kyle DE, Luxemburger C, Ter Kuile F, Peggins JO, Brewer TG, White NJ. (1996). Comparative bioavailability of oral, rectal, and intramuscular artemether in healthy subjects: Use of simultaneous measurement by high performance liquid chromatography and bioassay. Br J Clin Pharmacol 42: 599–604.
   PubMed Web of Science ®Google Scholar
• Titulaer HA, Zuidema J, Kager PA, Wetsteyn JC, Lugt CB, Merkus FW. (1990). The pharmacokinetics of artemisinin after oral, intramuscular and rectal administration to volunteers. J Pharm Pharmacol 42: 810–813.
   PubMed Web of Science ®Google Scholar
• Toovey S. (2006). Effects of weight, age, and time on artemether-lumefantrine associated ototoxicity and evidence of irreversibility. Travel Med Infect Dis 4:71–76.
   Google Scholar
• Toovey S. (2007). Are currently deployed artemisinins neurotoxic? Toxicol Lett 166:95–104. Erratum in: Toxicol Lett 168:91.
   Google Scholar
• Toovey S, Jamieson A. (2004a). Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether. Trans R Soc Trop Med Hyg 98:261–267; discussion 268–269.
   PubMed Web of Science ®Google Scholar
• Toovey S, Jamieson A. (2004b). Response to: Artemisinin derivatives: Toxic for laboratory animals safe for humans? Toxicol Lett 151:489–490; author reply 491–492.
   Google Scholar
• Tran TH, Day NP, Nguyen HP, Nguyen TH, Tran TH, Pham PL, Dinh XS, Ly VC, Ha V, Waller D, Peto TE, White NJ. (1996). A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med 335:76–83.
   PubMed Web of Science ®Google Scholar
• van Agtmael MA, Eggelte TA, van Boxtel CJ. (1999). Artemisinin drugs in the treatment of malaria: From medicinal herb to registered medication. Trends Pharmacol Sci 20: 199–205.
   PubMed Web of Science ®Google Scholar
• van Hensbroek M.B, Onyiorah E, Jaffar S, Schneider G, Palmer A, Frenkel J, Enwere G, Forck S, Nusmeijer A, Bennett S, Greenwood B, Kwiatkowski D. (1996). A trial of artemether or quinine in children with cerebral malaria. N Engl J Med 335:69–75.
   PubMed Web of Science ®Google Scholar
• van Vugt M, Ezzet F, Nosten F, Gathmann I, Wilairatana P, Looareesuwan S, White NJ. (1999). No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine. Am J Trop Med Hyg 61: 964–967.
   PubMed Web of Science ®Google Scholar
• van Vugt M, Angus BJ, Price RN, Mann C, Simpson J.A, Poletto C, Htoo SE, Looareesuwan S, White NJ, Nosten F. (2000). A case-control auditory evaluation of patients treated with artemisinin derivatives for multidrug-resistant Plasmodium falciparum malaria. Am J Trop Med Hyg 62: 65–69.
   PubMed Web of Science ®Google Scholar
• Wang TY. (1989). Follow-up observation on the therapeutic effects and remote reactions of artemisinin (Qinghaosu) and artemether in treating malaria in pregnant woman. J Tradit Chin Med 9:28–30.
   PubMedGoogle Scholar
• Wang Z, Qiu J, Guo TB, Liu A, Wang Y, Li Y, Zhang JZ. (2007). Anti-inflammatory properties and regulatory mechanism of a novel derivative of artemisinin in experimental autoimmune encephalomyelitis. J Immunol 179: 5958–5965.
   PubMed Web of Science ®Google Scholar
• Wartenberg M, Wolf S, Budde P, Grünheck F, Acker H, Hescheler J, Wartenberg G, Sauer H. (2003). The antimalaria agent artemisinin exerts antiangiogenic effects in mouse embryonic stem cell-derived embryoid bodies. Lab Invest 83: 1647–1655.
   PubMed Web of Science ®Google Scholar
• Wenisch C, Parschalk B, Zedwitz-Liebenstein K, Wernsdorfer W, Graninger W. (1997). The effect of artemisinin on granulocyte function assessed by flow cytometry. J Antimicrob Chemother 39: 99–101.
   PubMed Web of Science ®Google Scholar
• Wesche DL, DeCoster M.A, Tortella FC, Brewer TG. (1994). Neurotoxicity of artemisinin analogs in vitro. Antimicrob Agents Chemother 38: 1813–1819.
   PubMed Web of Science ®Google Scholar
• White NJ. (1994). Artemisinin: Current status. Trans R Soc Trop Med Hyg 88: S3–S4.
   PubMed Web of Science ®Google Scholar
• White NJ. (2000). Neurological dysfunction following malaria: Disease- or drug-related? Clin Infect Dis 30:836.
   Google Scholar
• White TE, Clark R.L. (2008). Sensitive periods for developmental toxicity of orally administered artesunate in the rat. Birth Defects Res B Dev Reprod Toxicol 83: 407–417.
   PubMed Web of Science ®Google Scholar
• White NJ, Ashley EA, Nosten F. (2006a). Toxic brainstem encephalopathy after artemisinin treatment for breast cancer. Ann Neurol 59:725–726. Comment on: Ann Neurol 2005;58:812–813.
   Google Scholar
• White TE, Bushdid PB, Ritter S, Laffan SB, Clark RL. (2006b). Artesunate-induced depletion of embryonic erythroblasts precedes embryolethality and teratogenicity in vivo. Birth Defects Res B Dev Reprod Toxicol 77: 413–429.
   PubMed Web of Science ®Google Scholar
• White TE, Lordi AW, Bushdid PB, Cox EM, Floyd LE, Fishman CE, et al. (2007). Autoradiography reveals specific targeting of embryonic and fetal blood cells by the anti-malarial artsunate. Birth Defects Res Part A 79:362.
   Google Scholar
• WHO Expert Committee on Malaria. (2000). WHO Technical Teport Series 892. 20th Report. Available at:http://rbm.who.int/docs/ecr20.pdf. Accessed August 13, 2009.
   Google Scholar
• Wootton DG, Opara H, Biagini GA, Kanjala MK, Duparc S, Kirby PL, Woessner M, Neate C, Nyirenda M, Blencowe H, Dube-Mbeye Q, Kanyok T, Ward S, Molyneux M, Dunyo S, Winstanley PA. (2008). Open-label comparative clinical study of chlorproguanil-dapsone fixed dose combination (Lapdap) alone or with three different doses of artesunate for uncomplicated Plasmodium falciparum malaria. PLoS One 3:e1779.
   Google Scholar
• World Health Organization. (2007). Assessment of the safety of artemisinin compounds in pregnancy. Available at: https://apps.who.int/tdr/publications/tdr-research-publications/artemisinin-compounds-pregnancy/pdf/artemisinin-compounds-pregnancy.pdf. Accessed August, 2009.
   Google Scholar
• World Health Organization. (2006). The Safety of Medicines in Public Health Programmes: Pharmacovigilance an Essential Tool. Geneva: WHO.
   Google Scholar
• Xiao S, Tanner M, N’Goran EK, Utzinger J, Chollet J, Bergquist R, Chen M, Zheng J. (2002). Recent investigations of artemether, a novel agent for the prevention of Schistosomiasis japonica, mansoni, and haematobia. Acta Trop 82: 175–181.
   PubMed Web of Science ®Google Scholar
• Xiao S, Yang Y, You Q, Utzinger J, Guo H, Peiying J, Mei J, Guo J, Bergquist R, Tanner M. (2002). Potential long-term toxicity of repeated orally administered doses of artemether in rats. Am J Trop Med Hyg 66: 30–34.
   Google Scholar
• Xie LH, Johnson TO, Weina PJ, Si Y, Haeberle A, Upadhyay R, Wong E, Li Q. (2005). Risk assessment and therapeutic indices of artesunate and artelinate in Plasmodium berghei-infected and uninfected rats. Int J Toxicol 24: 251–264.
   Google Scholar
• Xu H, He Y, Yang X, Liang L, Zhan Z, Ye Y. (2007). Anti-malarial agent artesunate inhibits TNF-α-induced production of proinflammatory cytokines via inhibition of NF-κB and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes. Rheumatology 46: 920–926.
   PubMed Web of Science ®Google Scholar
• Yang SX, Xie SS, Gao HL, Long ZZ. (1993). Artemisinin and its derivatives enhance T lymphocyte-mediated immune responses in normal mice and accelerate immunoreconstitution of mice with syngeneic bone marrow transplantation. Clin Immunol Immunopathol 69: 143–148.
   PubMedGoogle Scholar
• Ye XS, Cheng DX, Wang YQ. (1982). Effect of qinghaosu on the phagocytosis of peritoneal macrophages in mice. Acta Beijing Med Coll 14: 141–142.
   Google Scholar
• Zhang ZY, Yu SQ, Miao LY, Huang XY, Zhang YP, Zhu YP, Xia XH, Li DQ. (2008). Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: A randomized controller trial. J Chin Integr Med 6:134–138.
   PubMedGoogle Scholar
• Zhao M, Xue DB, Zheng B, Zhang WH, Pan SH, Sun B. (2007). Induction of apoptosis by artemisinin relieving the severity of inflammation in caerulein-induced acute pancreatitis. World J Gastroenterol 13: 5612–5617.
   PubMed Web of Science ®Google Scholar